Viewing Study NCT02125357


Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2026-02-07 @ 6:38 AM
Study NCT ID: NCT02125357
Status: COMPLETED
Last Update Posted: 2020-08-07
First Post: 2014-04-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sequencing Abiraterone and Enzalutamide in mCRPC
Sponsor: British Columbia Cancer Agency
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castration-Resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None sequencing View
None abiraterone View
None enzalutamide View
None metastatic castration-resistant prostate cancer View
None randomized View